Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Comment by duskwon Nov 15, 2012 3:32pm
471 Views
Post# 20606485

RE: RE: RE: RE: SOME QUICK HEM NUMBERS

RE: RE: RE: RE: SOME QUICK HEM NUMBERS

I think they want to see the numbers before saying the shares are worth more. At 0.60c, they're saying the company is worth about 36 million. That is rather surprising considering their revenue for their core business is probably going to be in the 60+ million range, and probably profitable into 2013. Even at 0.8x sales, they would be valued at 48 million, or 0.80c.

Not sure how they came up with 0.60. I think they are just throwing in the towel and want to be done with it. Hopefully RH can prove everybody wrong... 

Consider: He did a great job of selling Outback to CSI in the first place, at a high price.. so we know he's a good salesguy.  If we wants to tell HEM, he'll get top dollar I'm sure.

Consider: He has millions of HEM shares... he wants more than anyone to see the share price go up, much more than SK probably wanted

Consider: He built Outback from the ground-up.. and he knows the PrecAg business better than anyone

Consider: They are moving from a relatively high-cost region (Calgary) to low-cost (Kansas).

Final thing to consider - the markets always look forward. These will be a few tough quarters, no doubt. But going into late 2013, 2014, 2015.. you can see potential for huge EPS growth now that they will have their costs under control. Growing EPS & revenues and holding the line on expenses typically means a huge increase in share price.. but investors will need to be patient.. It's not going to happen overnight. Sad that it's taken so long.. but maybe HEM will end up being a decent investment afterall.

In any case, I don't think there is much point selling at these levels. May as while either ride it down to 0 (doubtfull), or hang on for future rewards. JMHO

 

Bullboard Posts